Key | % Net Assets |
---|---|
GlaxoSmithKline | 5.7% |
Royal Dutch Shell | 5.6% |
Vodafone | 4.4% |
British American Tobacco | 3.8% |
Other | 80.5% |
Name | % Net Assets |
---|---|
GlaxoSmithKline | 5.7% |
Royal Dutch Shell | 5.6% |
Vodafone | 4.4% |
British American Tobacco | 3.8% |
Unilever | 2.9% |
British American Tobacco | 2.8% |
BT Group | 2.7% |
Imperial Tobacco | 2.7% |
HSBC Holdings | 2.5% |
Centrica | 2.2% |
No asset data available.
Date | 09-May-2022 |
---|---|
NAV | 266.40p |
Currency | GBP |
Change | -6.20p |
% | -2.27% |
YTD change | 266.40p |
YTD % | n/a |
Fund Inception | 18/10/2004 |
---|---|
Fund Manager | n/a |
TER | 1.81 (31-Mar-2014) |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.70% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.11 |
You are here: research